View in EDS

Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types.

Saved in:
Bibliographic Details
Title: Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types.
Authors: Oh J; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, 03080, Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Korea., Hwa C; School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, 02841, Korea.; BK21FOUR R&E Center for Learning Health Systems, Korea University, Seoul, 02841, Korea.; Department of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Korea., Jang D; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea., Shin S; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea., Lee SJ; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea., Kim J; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea., Lee SE; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea., Jung HR; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea., Oh Y; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea., Jang G; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea., Kwon O; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea.; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea., An JY; School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, 02841, Korea. joonan30@korea.ac.kr.; BK21FOUR R&E Center for Learning Health Systems, Korea University, Seoul, 02841, Korea. joonan30@korea.ac.kr., Cho SY; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, 03080, Korea. csybio@snu.ac.kr.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea. csybio@snu.ac.kr.; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea. csybio@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, 03080, Korea. csybio@snu.ac.kr.
Source: Experimental & molecular medicine [Exp Mol Med] 2022 Jul; Vol. 54 (7), pp. 906-921. Date of Electronic Publication: 2022 Jul 06.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2092-6413 (Electronic) Linking ISSN: 12263613 NLM ISO Abbreviation: Exp Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35794212
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Oh+J%22">Oh J</searchLink>; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, 03080, Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Hwa+C%22">Hwa C</searchLink>; School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, 02841, Korea.; BK21FOUR R&E Center for Learning Health Systems, Korea University, Seoul, 02841, Korea.; Department of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Korea.<br /><searchLink fieldCode="AU" term="%22Jang+D%22">Jang D</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Shin+S%22">Shin S</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SJ%22">Lee SJ</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SE%22">Lee SE</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Jung+HR%22">Jung HR</searchLink>; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Oh+Y%22">Oh Y</searchLink>; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Jang+G%22">Jang G</searchLink>; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22Kwon+O%22">Kwon O</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea.; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea.<br /><searchLink fieldCode="AU" term="%22An+JY%22">An JY</searchLink>; School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, 02841, Korea. joonan30@korea.ac.kr.; BK21FOUR R&E Center for Learning Health Systems, Korea University, Seoul, 02841, Korea. joonan30@korea.ac.kr.<br /><searchLink fieldCode="AU" term="%22Cho+SY%22">Cho SY</searchLink>; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, 03080, Korea. csybio@snu.ac.kr.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea. csybio@snu.ac.kr.; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Korea. csybio@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, 03080, Korea. csybio@snu.ac.kr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607880%22">Experimental & molecular medicine</searchLink> [Exp Mol Med] 2022 Jul; Vol. 54 (7), pp. 906-921. <i>Date of Electronic Publication: </i>2022 Jul 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9607880 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2092-6413 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2212263613%22">12263613 </searchLink><i>NLM ISO Abbreviation: </i>Exp Mol Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35794212
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s12276-022-00795-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 906
    Titles:
      – TitleFull: Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Oh J
      – PersonEntity:
          Name:
            NameFull: Hwa C
      – PersonEntity:
          Name:
            NameFull: Jang D
      – PersonEntity:
          Name:
            NameFull: Shin S
      – PersonEntity:
          Name:
            NameFull: Lee SJ
      – PersonEntity:
          Name:
            NameFull: Kim J
      – PersonEntity:
          Name:
            NameFull: Lee SE
      – PersonEntity:
          Name:
            NameFull: Jung HR
      – PersonEntity:
          Name:
            NameFull: Oh Y
      – PersonEntity:
          Name:
            NameFull: Jang G
      – PersonEntity:
          Name:
            NameFull: Kwon O
      – PersonEntity:
          Name:
            NameFull: An JY
      – PersonEntity:
          Name:
            NameFull: Cho SY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2022 Jul
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2092-6413
          Numbering:
            – Type: volume
              Value: 54
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Experimental & molecular medicine
              Type: main
ResultId 1